Kiadis announces presentations at the 2020 ASH Annual Meeting and Exposition
Amsterdam, The Netherlands, November 13, 2020 – Kiadis Pharma N.V. (“Kiadis” or the “Company”) (Euronext…
Year: 2020
Innate Pharma Receives Prime Designation From the European Medicines Agency for Lacutamab in Sézary Syndrome
Priority Medicines (PRIME) designation supports the potential for lacutamab to benefit Sézary Syndrome patients in…
ObsEva SA to present at Jefferies Virtual London Healthcare Conference, November 17 – 19, 2020
Geneva, Switzerland and Boston, MA – November 13, 2020 – ObsEva SA (NASDAQ: OBSV /…
INNATE PHARMA RECEIVES PRIME DESIGNATION FROM THE EUROPEAN MEDICINES AGENCY FOR LACUTAMAB IN SÉZARY SYNDROME
Priority Medicines (PRIME) designation supports the potential for lacutamab to benefit Sézary Syndrome patients in…
Organogenesis Holdings Inc. Announces Pricing of Public Offering of Class A Common Stock
CANTON, Mass., Nov. 13, 2020 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading…
Keros Therapeutics Announces Pricing of Public Offering of Common Stock
LEXINGTON, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a…
MediciNova Announces Presentation of Positive Findings on MN-001 (tipelukast) in Acute Liver Injury Model at The Liver Meeting Digital Experience™ 2020
LA JOLLA, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded…
Aileron Therapeutics Reports Third Quarter 2020 Financial Results and Business Highlights
Presented positive clinical proof-of-concept data from ongoing ALRN-6924 Phase 1b trial in patients with p53-mutated…
PLx Pharma Inc. 2020 Third Quarter Financial Results and Business Update Conference Call Rescheduled to November 16, 2020
SPARTA, N.J., Nov. 12, 2020 (GLOBE NEWSWIRE) — PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or…
Processa Pharmaceuticals Announces Third Quarter 2020 Results, Provides Corporate Update
Highlights include closing $19.2 million public offering, uplisting to Nasdaq, and positive progress with multiple…
Timber Pharmaceuticals Provides Business Update and Announces Third Quarter 2020 Financial Results
WOODCLIFF LAKE, NJ, Nov. 12, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Timber Pharmaceuticals, Inc….
Cassava Sciences Announces Proposed Public Offering of Common Stock
AUSTIN, Texas, Nov. 12, 2020 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA) (the “Company”…
EXMceuticals Provides Bi-Weekly Default Status Report
VANCOUVER, British Columbia, Nov. 12, 2020 (GLOBE NEWSWIRE) — EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2)…
T2 Biosystems to Participate in the Canaccord Genuity Virtual MedTech & Diagnostics Forum
LEXINGTON, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the…
Tonix Pharmaceuticals Outlines New Statistical Method to Analyze Future PTSD Studies at the 3rd Annual Neuropsychiatric Drug Development Summit
Increasing Placebo Responses in PTSD Drug Trials Raise Questions About Current Methods of Measuring or…
Agios Announces FDA Orphan Drug Designation Granted to Mitapivat for Treatment of Sickle Cell Disease
CAMBRIDGE, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader…
ERYTECH to Present at Jefferies Virtual Healthcare Conference
LYON, France and CAMBRIDGE, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) — ERYTECH Pharma (Nasdaq &…
Osmotica Pharmaceuticals plc to Present at 2020 Jefferies Virtual London Healthcare Conference
BRIDGEWATER, N.J., Nov. 12, 2020 (GLOBE NEWSWIRE) — Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or…
Vaxcyte Reports Third Quarter 2020 Financial Results and Provides Business Update
FOSTER CITY, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) — Vaxcyte, Inc., formerly known as SutroVax,…
Harpoon Therapeutics Presents Encouraging Preclinical Data for HPN601 EpCAM ProTriTAC™ Program at 35th SITC Annual Meeting
SOUTH SAN FRANCISCO, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (NASDAQ: HARP),…